Analysis of autophagy in DLBCL reveals subtype-specific differences and the preferential targeting of ULK1 inhibition in GCB-DLBCL provides a rationale as a new therapeutic approach

对弥漫性大B细胞淋巴瘤（DLBCL）中自噬的分析揭示了亚型特异性差异，而优先靶向抑制生发中心B细胞型弥漫性大B细胞淋巴瘤（GCB-DLBCL）中的ULK1，为一种新的治疗方法提供了理论依据。